Your support helps NAMA make a difference.Treasurer: J.L. Sotheran, PhD, CMA Please confirm your Donation with our Treasurer (with a copy to the Membership Director). |
Your support helps NAMA make a difference.Treasurer: J.L. Sotheran, PhD, CMA Please confirm your Donation with our Treasurer (with a copy to the Membership Director). |
The Basic Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs. Medication Assisted Treatment Basic clinical information about methadone and buprenorphine treatment. Regulations and Accreditation The federal regulations will be explained: What they are and…
20th Anniversary National Methadone Conference American Association for the Treatment of Opioid Dependence October 16-20, 2004 – Orlando, Florida Saturday: October 16, 2004 Preconference Events The Certified Methadone Advocate Course Sunday: October 17, 2004 Special Meeting Patient Support Community and Education Project Meeting Monday: October 18, 2004 NAMA Organizational Meeting Wednesday: October 20, 2004 Workshop…
NAMA Organizational Meeting Monday, October 8th, 7 P.M. Chairs Jo Sotheran, NAMA Board of Directors (Treasurer) Joycelyn Woods, NAMA Board of Directors (President) As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee). Jo Sotheran introduces the reasons…
This list is not a complete list, it is only intended as a starting point. Please use the SAMHSA Program Locator to search further. Allegany Allegany County MAT Program 12501-12503 Willowbrook Road Cumberland, MD 21501 Phone: (301) 759-5050 Fax: (301) 777-2098 Anne Arundel Anne Arundel Cty Health Department Adult Addiction Services 2200 Somerville Road Annapolis,…
USE OF HIGHER-DOSE METHADONE By Sarz Maxwell MD & Marc Shinderman MD Center for Addictive Problems 609 N Wells Chicago IL 60610 Abstract Using signs, symptoms and serum methadone levels to guide evaluation, we treated 188 patients in a methadone maintenance program with doses of methadone exceeding 100 mg/d. The mean dose…
Policy Statement Number 7 January 1997 Methadone treatment has been in existence now for over thirty years returning to society more productive individuals than any other treatment modality. Yet, despite this success it is disparaged and misunderstood which has translated into bias and discrimination not only for the consumer of the treatment as even those…